Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    Kearns-Sayre Syndrome
Show Display Options
Rank Status Study
1 Enrolling by invitation Nutritional Assessment in Mitochondrial Cytopathy
Conditions: Mitochondrial Diseases;   Mitochondrial Myopathies;   Mitochondrial Cytopathies
Intervention:
2 Recruiting Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
3 Active, not recruiting EPI-743 for Mitochondrial Respiratory Chain Diseases
Condition: Mitochondrial Diseases
Intervention: Drug: EPI-743

Indicates status has not been verified in more than two years